Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  valproic acid
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-23 of 23 for your search:
Start Over
Study on All-Trans Retinoic Acid, Induction and Consolidation Therapy, and Pegfilgrastim After Consolidation Therapy in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 to 60
Sponsor: Other
Protocol IDs: AMLSG07-04, NCT00151242
Differentiation Induction in Acute Myelogenous Leukemia
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: REK-Vestnr21503, NCT00175812
Valproic Acid With Temozolomide and Radiation Therapy to Treat Brain Tumors
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 90
Sponsor: NCI
Protocol IDs: 060112, 06-C-0112, NCI-06-C-0112, NCI-P6800, NCT00313664, NCT00302159
Phase II 5-Azacytidine Plus VPA Plus ATRA
Phase: Phase II
Type: Treatment
Status: Completed
Age: 3 and over
Sponsor: Other
Protocol IDs: 2004-0799, NCT00326170
5-azacytidine Valproic Acid and ATRA in AML and High Risk MDS
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: P050202, NCT00339196
Decitabine (DAC) w/ or w/o Valproic Acid (VPA) in Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
Phase: Phase II
Type: Treatment
Status: Closed
Age: Not specified
Sponsor: Other
Protocol IDs: 2006-0686, NCI-2012-01396, NCT00414310
PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: MDS0205, NCT00439673
Phase II Study of Valproate and Doxorubicin in Malignant Mesothelioma
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: ELCWP-01062, NCT00634205
Valproic Acid and Platinum-based Chemoradiation in Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: Under 60
Sponsor: Other
Protocol IDs: 327/11, NCT01695122
Decitabine and Valproic Acid in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-01447, NCI-6236, OSU-2003C0094, CDR0000355412, 0336, 6236, R21CA110496, U01CA076576, OSU-0336, NCT00079378
Decitabine and Valproic Acid in Treating Patients With Non-Small Cell Lung Cancer
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-01451, NCI-6237, OSU-2003C0087, OSU-0346, CDR0000367115, 6237, U01CA076576, NCT00084981
Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 2 to 21
Sponsor: NCI, Other
Protocol IDs: ADVL0419, COG-ADVL0419, NCI-05-C-0235, NCI-P6631, CDR0000417845, NCT00107458
Decitabine With or Without Valproic Acid in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-01465, 0475, CDR0000426523, OSU-0475, NCI-6997, OSU-2004C0119, U01CA076576, 6997, NCT00109824
Valproic Acid-Based 2-Agent Oral Regimens for Patients With Advanced Solid Tumor
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2007-0170, NCT00495872
Azacytidine and Valproic Acid in Patients With Advanced Cancers
Phase: Phase I
Type: Treatment
Status: Completed
Age: 2 and over
Sponsor: Other
Protocol IDs: 2004-0735, NCT00496444
Valproate and Etoposide for Patients With Neuronal Tumors and Brain Metastases
Phase: Phase I
Type: Treatment
Status: Completed
Age: Any age
Sponsor: Other
Protocol IDs: 2007-0370, NCT00513162
Azacitidine and Valproic Acid Plus Carboplatin in Patients With Ovarian Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: 2007-0030, NCT00529022
Valproic Acid and Bevacizumab in Patients With Advanced Cancer
Phase: Phase I
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: 2005-0676, NCT00530907
Phase I Trial of Valproic Acid and Epirubicin in Solid Tumor Malignancies
Phase: Phase I
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: MCC-13693, USFIRB#101881, NCT00246103
Use of Hydralzaine and Valproic Acid in Advanced Solid Tumor Malignancies
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: INST 0712C, NCI-2011-02651, NCT00996060
Valproic Acid in Treating Patients With Kaposi's Sarcoma
Phase: No phase specified
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: AMC-038, U01CA070019, CDR0000349348, NCT00075777
Start Over